Envigo paves new first-in-human trial solution

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Ipopba)
(Image: Getty/Ipopba)

Related tags: Clinical trial, Clinical trial data, Clinical trial design, Research models

The non-clinical contract research services and research model provider Envigo launches a new solution it says optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.

Dubbed Pathway, the solution is designed to manage the entire safety assessment process, integrating safety assessment study types and bioanalytical support with scientific and regulatory consulting, program design and project management.

“Our deep expertise in the complex fields of biologics and advanced therapies adds particular value to our customers with drug development programs in these growing categories. On our customers’ behalf, we frequently work with regulators to determine the most appropriate interpretation of regulatory guidance as it applies to a specific therapeutic,”​ Lee Coney, Envigo’s chief scientific officer, said in a press release.

Coney said Pathway leverages the company’s “beginning-to-end” ​understanding of the safety assessment process, and “optimizes the journey to first-in-human studies.”

“Experience of designing and conducting studies in a wide range of therapeutic modalities, and in working with regulatory agencies around the world, means we are able to anticipate the needs of a program at design stage, plan studies accordingly, and manage an optimal timeline of study execution,”​ he added in the release. 

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars